This one-day conference is designed to show the breadth of multidisciplinary research employed to strengthen health systems in low- and middle-income countries. Key-note speakers will introduce participants to a range of issues from across the spectrum of health systems research. An opportunity to find collaboration opportunities, and showcase your work by submitting an abstract. Thursday 6th December at Saint Antony's College, Oxford.
This Symposium will highlight areas of stem cell research with trajectories towards treatments of diseases including retinopathies, metabolic and genetic skin disorders, neurdegeneration, musculoskeletal disease, heart failure and cancer. St Hugh's College, 12 - 13 November 2018. Register for this event until 11 November 2018.
Prof. Sarah Rowland-Jones' work mainly focuses on anti-viral immunity, and in particular how immune responses modify the outcome of HIV infection. Her research aims to contribute to the design of vaccines and immunotherapies against HIV infection, including HIV-2 infection, in developing countries where an effective vaccine is desperately needed.
A team of Oxford University researchers have worked on behalf of UK Biobank to apply sophisticated new statistical techniques to genetic information from all 500,000 volunteer UK Biobank participants. They have ensured high data quality and been able to impute the number of testable genetic variants – the letters in our DNA code that vary from person to person - from 800,000 to 96 million, a more than 100-fold increase in useful data. Imputation compares the selected genotyped DNA with analysis of the full human genome, to allow scientists to accurately predict DNA code at non-selected sections.
Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease with limited treatment options. Up to 40% of patients with IBD fail to respond to conventional therapies, partly due to our limited understanding of the cells that form the large intestine, but also how they change in in patients affected by this disease. The study published today by the group of Professor Alison Simmons at the MRC Human Immunology Unit paves the way for better treatments for IBD by providing the first detailed single cell resolution analysis of colon cells in health and disease.
Pneumothorax is a common condition which can affect anyone where air leaks from the lung and causes lung collapse. Researchers from the Clinical Trials Support Unit and Oxford Respiratory Trials Unit have conducted the world’s largest ever analysis of pneumothorax (over 170,000 cases) using hospital records, and demonstrated that this condition is increasing. The reasons for this are not clear, but provide important data on trends in this disease, and highlight the need for further research in to treatment and prevention
Thursday 18 October 2018 , 1 - 2 pm
Lecture Theatre 1
Respiratory: "NIV in COPD", Dr Annabel Nickol
Acute General Medicine Firm C: "The foreign leg", Dr Catherine Ashton and Prof Sarah Pendlebury
Chair: Prof Chris Conlon